Author

Mathieu Rouanne

Columbia UniversityORCID 0000-0003-2970-4821Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Fangda LiiD· 2 shared Nicholas ArpaiaiD· 2 shared Rosa L. VincentiD· 2 shared Tal DaninoiD· 2 shared Ana Vardoshivilli· 1 shared Andrew RedentiiD· 1 shared Benjamin J. Redenti· 1 shared Candice R. GurbatriiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Fangda LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyScience Translational MedicinePeer-reviewedJul 22, 2026

Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy

Mathieu Rouanne, Noah Chen, Dylan L. Mariuzza…·Nicholas Arpaia

This study shows engineered E. coli expressing CXCL13 enhances bladder cancer immunotherapy when combined with PD-1 blockade by promoting tumor-specific antibody responses.

2 citations

mouseproteomics

𝕏 PostBluesky

Synthetic BiologyNaturePeer-reviewedOct 16, 2024

Probiotic neoantigen delivery vectors for precision cancer immunotherapy

Andrew Redenti, Jongwon Im, Benjamin J. Redenti…·Nicholas Arpaia

This study engineers probiotic E. coli to deliver neoantigen peptides, enhancing T cell immunity and reducing tumor growth in mice.

201 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky